InvestorsHub Logo
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Monday, 07/20/2020 11:49:24 AM

Monday, July 20, 2020 11:49:24 AM

Post# of 69
ASMB—(+10%)—inks deal with BGNE for Greater-China development/commercialization of ASMB’s HBV core inhibitors—$40M up-front cash for ASMB ($500M biobucks):

https://www.globenewswire.com/news-release/2020/07/20/2064219/0/en/Assembly-Biosciences-and-BeiGene-Announce-License-and-Collaboration-Agreement-in-China-for-Assembly-s-Portfolio-of-Three-Clinical-Stage-Core-Inhibitors-for-Chronic-Hepatitis-B-Infe.html

*Includes Taiwan, Hong Kong, Macao.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASMB News